The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Jiangsu Hengrui Medicine
A phase I study of SHR6390, a cyclin-dependent kinase 4/6 inhibitor in patients with advanced breast cancer (ABC).
 
Pin Zhang
No Relationships to Disclose
 
Binghe Xu
Speakers' Bureau - AstraZeneca; Eisai; Pfizer; Roche
Research Funding - Jiangsu Hengrui Medicine (Inst)
 
Lin Gui
No Relationships to Disclose
 
Wenna Wang
No Relationships to Disclose
 
Meng Xiu
No Relationships to Disclose
 
Xiao Zhang
Employment - Jiangsu Hengrui Medicine
 
Guilan Sun
Employment - Jiangsu Hengrui Medicine
 
Xiaoyu Zhu
Employment - Jiangsu Hengrui Medicine
 
Jianjun Zou
No Relationships to Disclose